Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CHAPUIS

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Nature Biomedical Engineering|October 22, 2025
Collagen-binding IL-12-armoured STEAP1 CAR-T cells reduce toxicity and treat prostate cancer in mouse modelsKoichi Sasaki, Vipul Bhatia, Yuta Asano, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccineEmily S Ford, Alvason Li, Kerry J Laing, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2022
An In Vivo Model of Human Macrophages in Metastatic MelanomaValentin Voillet, Trisha R Berger, Kelly M McKenna, et al.
Plos One|June 6, 2024
qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissueShalini Pullarkat, Graeme Black, Marie Bleakley, et al.
JCI Insight|August 12, 2024
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccineEmily S Ford, Alvason Z Li, Kerry J Laing, et al.
Transplantation and Cellular Therapy|May 17, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing With Engineered Immune Effector CellsViktoria Blumenberg, Caroline Diorio, Jordan Gauthier, et al.
The Lancet. Oncology|July 6, 2023
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trialAndrew J Cowan, Margot J Pont, Blythe D Sather, et al.
Haematologica|March 13, 2025
Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow upAndrew J Portuguese, Jennifer J Huang, Yein Jeon, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and PersistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Eagan, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell CarcinomaYuta Asano, Joshua Veatch, Megan McAfee, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Nature Biomedical Engineering|October 22, 2025
Collagen-binding IL-12-armoured STEAP1 CAR-T cells reduce toxicity and treat prostate cancer in mouse modelsKoichi Sasaki, Vipul Bhatia, Yuta Asano, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccineEmily S Ford, Alvason Li, Kerry J Laing, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2022
An In Vivo Model of Human Macrophages in Metastatic MelanomaValentin Voillet, Trisha R Berger, Kelly M McKenna, et al.
Plos One|June 6, 2024
qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissueShalini Pullarkat, Graeme Black, Marie Bleakley, et al.
JCI Insight|August 12, 2024
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccineEmily S Ford, Alvason Z Li, Kerry J Laing, et al.
Transplantation and Cellular Therapy|May 17, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing With Engineered Immune Effector CellsViktoria Blumenberg, Caroline Diorio, Jordan Gauthier, et al.
The Lancet. Oncology|July 6, 2023
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trialAndrew J Cowan, Margot J Pont, Blythe D Sather, et al.
Haematologica|March 13, 2025
Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow upAndrew J Portuguese, Jennifer J Huang, Yein Jeon, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and PersistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Eagan, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell CarcinomaYuta Asano, Joshua Veatch, Megan McAfee, et al.
Pageof 11